Lenvima (lenvatinib)

pCPA File Number: 20895
Negotiation Status:
Concluded with an LOI
Indication(s):
Differentiated Thyroid Cancer
Sponsor/Manufacturer:
Eisai Limited
CDA-AMC Project Number:
PC0080-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: